Callan Family Office’s Morningstar MORN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$846K Buy
5,421
+1,152
+27% +$200K 0.02% 642
2026
Q1
$722K Buy
4,269
+1,039
+32% +$193K 0.02% 648
2025
Q4
$702K Buy
3,230
+2,234
+224% +$484K 0.02% 660
2025
Q3
$231K Sell
996
-2,009
-67% -$536K 0.01% 790
2025
Q2
$943K Buy
3,005
+2,141
+248% +$634K 0.03% 421
2025
Q1
$259K Buy
864
+82
+10% +$25.8K 0.02% 461
2024
Q4
$263K Buy
+782
New +$267K 0.02% 524

Other funds holding MORN

Callan Family Office's MORN Position: Q2 2026 in Review

Callan Family Office increased its Morningstar (MORN) stake by 27% in Q2 2026, buying an estimated $200K and bringing the position to 5,421 shares worth $846K. The position accounts for 0.02% of the portfolio, ranked #642.

Callan Family Office first reported a position in MORN in Q4 2024 and has held it in 7 quarters since. The position peaked at $943K in Q2 2025. 419 funds tracked by Wall St. Rank hold MORN as of Q2 2026.

  • Callan Family Office held 5,421 shares of Morningstar worth $846K as of Q2 2026.
  • Callan Family Office bought 1,152 Morningstar shares in Q2 2026, an estimated $200K.
  • Morningstar made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #642 holding.
  • Callan Family Office first reported a position in Morningstar in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Morningstar position peaked at $943K in Q2 2025.
  • 419 funds tracked by Wall St. Rank held Morningstar as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.